|
|
|||||||
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
03-22-2016, 04:29 PM
|
|||
|
|||
BRIEF-Biopharmx says it received IRB approval to start Phase 4 study of Violet molec
BRIEF-Biopharmx says it received IRB approval to start Phase 4 study of Violet molecular iodine
* received institutional review board (IRB) approval to initiate Phase 4 study of Violet molecular iodine supplement for fibrocystic breast condition & cyclic mastalgia Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)  ??????? ??????: BRIEF-Biopharmx says it received IRB approval to start Phase 4 study of Violet molec || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري